How Do You Assess an MPN Transforming from One to Another?

Published on

Topics include: Understanding

Dr. Srdan Verstovsek and Dr. Carlos Bueso-Ramos, from MD Anderson Cancer Center, discuss the transformation of MPNs (myeloproliferative neoplasms). The experts discuss the factors that are included in the assessment of the transformation, including fibrosis, blood counts, platelets, the spleen and anemia, among others.

 

The Ask the Expert series is sponsored through an education grant to the Patient Empowerment Network from Incyte Corporation.

View more programs featuring and

Transcript

Please remember the opinions expressed on Patient Power are not necessarily the views of our sponsors, contributors, partners or Patient Power. Our discussions are not a substitute for seeking medical advice or care from your own doctor. That’s how you’ll get care that’s most appropriate for you.

There are cases of ET patients, the high platelets that acquire higher red blood cells, ET going to PV.  Not that the patient has two diseases at the same time but that the biology of the disease after 10 or 15 years has changed, and now the patient requires phlebotomy, bloodletting, to decrease their red cell blood count.  So it's not that simple.  There are multiple factors.  Fibrosis is paramount to look at, but it's not the critical one.  

Please remember the opinions expressed on Patient Power are not necessarily the views of our sponsors, contributors, partners or Patient Power. Our discussions are not a substitute for seeking medical advice or care from your own doctor. That’s how you’ll get care that’s most appropriate for you.

Related Programs

Treating Myelofibrosis: What Are the Goals for the Future?

What more needs to be done in treating myelofibrosis? Dr. Srdan Verstovsek, a leading MPN expert, outlines his thoughts on the remaining goals of treatment.

Published:

Doctor Turned Cancer Survivor Counsels Newly Diagnosed

Dr. Bob Boyd, a former OB-GYN, was diagnosed with advanced cancer after a routine exam. Now, as a survivor, he gives hope to the newly diagnosed and encourages other survivors to do the same. Watch.

Published:

What Factors Play a Role in MPN Progression?

MD Anderson Cancer Center expert, Dr. Jorge Cortes talks about the range of factors—including age and stage of disease—that may contribute to MPN disease progression.

Published:

Advertisement
Join Our Community Register for Events Read Our Latest Blog
Advertisement

Page last updated on May 29, 2014